level, may effectively control this syndrome and prevent outcomes such as diabetes.
Recently efforts have focused on translating this knowledge into changes in clinical practice, allowing both clinicians and researchers to define and manage this syndrome better. In 2001 the American National Cholesterol Education Program (NCEP) issued its Adult Treatment Panel III (ATP III) guidelines outlining criteria for the diagnosis of metabolic syndrome. 1 In the same year, the US Centers for Disease Control and Prevention, at the request of the American Association of Clinical Endocrinologists, introduced a new ICD-9-CM code (277.7) and a set of clinical descriptors of dysmetabolic syndrome X.
The rising prevalence of this syndrome in industrialized nations has largely been attributed to lifestyle changes in diet and physical activity, leading to higher obesity rates. In 2002 analysis of data from the Third National Health and Nutrition Examination Survey collected between 1988 and 1994 indicated that a whopping 44% of the American population aged 50 years and older had the metabolic syndrome, according to NCEP definitions. 2 The prevalence increased with age, elevated body weight and membership in certain ethnic populations such as Hispanics and Native Americans. Additional research indicated that the syndrome was associated with a tripling of cardiovascular disease mortality and a doubling of overall mortality in a cohort of middle-aged Finnish men. 3 Given that more than 40% of adults over age 50 are estimated to have this syndrome, 2 these results have tremendous implications for future disease burden related to diabetes and coronary artery disease.
Clinical practice: According to ATP III criteria, metabolic syndrome is present in people with 3 or more of the risk factors (see list at left). For patients aged 35 and older in whom the syndrome is suspected, primary care physicians can easily measure the blood pressure, fasting glucose level, and high-and low-density lipoprotein cholesterol levels. To measure waist circumference, they need to place a tape measure at the level of the superior iliac crest, parallel to the floor, at the end of a patient's relaxed expiration. 4 Managing metabolic syndrome involves both lifestyle modification and, if required, drug therapy. First-line therapies for all risk factors associated with the syndrome are dietary changes and increased physical activity aimed at weight reduction. This means eating small, regular, balanced meals following Health Canada's food guide (www.hc-sc.gc.ca/hpfbdgpsa/onpp-bppn/food_guide_ rainbow_e.html) and participating in daily regular exercise along the lines of Health Canada's physical activity guide (www .hc-sc.gc.ca/hppb/paguide). Additional therapeutic interventions include treatment of hypertension, use of ASA in patients with coronary artery disease to reduce the prothrombotic state and treatment of elevated triglyceride and low HDL cholesterol levels, if required. Corbis 14.5%, number-needed-totreat 6.9). However, combatting the inertia of sedentary and indulgent habits may be more difficult than preventing these habits in the first place. Global efforts, extending from schoolyard grounds to the heights of the World Health Organization, are currently committed to promoting healthy diets and activity levels and preventing obesity and deconditioning through stakeholder involvement, public and private collaboration, advocacy, evidence and play (www.who .int/hpr/global.strategy.shtml). 
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